Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil.
Kuypers DR, Vanrenterghem Y, Squifflet JP, Mourad M, Abramowicz D, Oellerich M, Armstrong V, Shipkova M, Daems J. Kuypers DR, et al. Among authors: vanrenterghem y. Ther Drug Monit. 2003 Oct;25(5):609-22. doi: 10.1097/00007691-200310000-00011. Ther Drug Monit. 2003. PMID: 14508385
Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y. Kuypers DR, et al. Among authors: vanrenterghem y. Clin Pharmacokinet. 2004;43(11):741-62. doi: 10.2165/00003088-200443110-00005. Clin Pharmacokinet. 2004. PMID: 15301578 Clinical Trial.
The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients.
Kuypers DR, Naesens M, Vermeire S, Vanrenterghem Y. Kuypers DR, et al. Among authors: vanrenterghem y. Clin Pharmacol Ther. 2005 Oct;78(4):351-61. doi: 10.1016/j.clpt.2005.06.007. Clin Pharmacol Ther. 2005. PMID: 16198654 Clinical Trial.
368 results